# Gaoling Pharmacy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gaoling-pharmacy

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.highlightpharma.com
- Latest round: Series B (Jul 2, 2021)
- Investors on record: 4

## About

Established in 2017, and based in Hangzhou, China, Gaoling Pharmacy is a medical company that develops drugs for autoimmunity disease and tumor. A majority of team members have acquired Doctor's Degrees. In January 2025, Gaoling Pharmacy raised CNY 150 million in pre-series C funding from new investors Infinity Group, Kangjun Capital, and Huajin Capital, with participation from returning investor Hankang Capital.

Gaoling Pharmacy is a medical company that focuses on curing serious illnesses and developing drugs around the globe. The product of the company is TYK2/JAK1 dual inhibitor that can be used to cure Alzheimer's and Parkinson's disease.

The company generates revenue by developing drugs for serious illness.

According to the news, the company will use the funds for clinical development and promoting pipelines at an early stage.

## Funding rounds

- Series B, Jul 2, 2021 — Kaitai Capital, Efung Capital, Hankang Capital
- Series B, Jan 26, 2021 — Kaitai Capital, Efung Capital, Lake Ventures

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series B
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series B
- Lake Ventures — Series B
- Hankang Capital (https://capitalatlas.ai/funds/hankang-capital) — Series B